8-Br-cAMP sodium
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 563425

CAS#: 76939-46-3

Description: 8-Br-cAMP sodium is a cell-permeable activator of protein kinase A.


Chemical Structure

img
8-Br-cAMP sodium
CAS# 76939-46-3

Theoretical Analysis

MedKoo Cat#: 563425
Name: 8-Br-cAMP sodium
CAS#: 76939-46-3
Chemical Formula: C10H10BrN5NaO6P
Exact Mass: 428.945
Molecular Weight: 430.08
Elemental Analysis: C, 27.93; H, 2.34; Br, 18.58; N, 16.28; Na, 5.35; O, 22.32; P, 7.20

Price and Availability

Size Price Availability Quantity
5.0mg USD 210.0 2 Weeks
10.0mg USD 340.0 2 Weeks
25.0mg USD 540.0 2 Weeks
Bulk inquiry

Synonym: 8-Br-cAMP sodium; 8 Br cAMP Na; 8BrcAMP sodium; 8-Br-cAMP Na;

IUPAC/Chemical Name: sodium (4aR,6R,7R,7aS)-6-(6-amino-8-bromo-9H-purin-9-yl)-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide

InChi Key: DMRMZQATXPQOTP-GWTDSMLYSA-M

InChi Code: InChI=1S/C10H11BrN5O6P.Na/c11-10-15-4-7(12)13-2-14-8(4)16(10)9-5(17)6-3(21-9)1-20-23(18,19)22-6;/h2-3,5-6,9,17H,1H2,(H,18,19)(H2,12,13,14);/q;+1/p-1/t3-,5-,6-,9-;/m1./s1

SMILES Code: O[C@H]1[C@@H](O[C@H]2[C@H]1OP(OC2)([O-])=O)N3C(Br)=NC4=C3N=CN=C4N.[Na+]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

Preparing Stock Solutions

The following data is based on the product molecular weight 430.08 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Pujol-Giménez J, Pérez A, Reyes AM, Loo DD, Lostao MP. Functional characterization of the human facilitative glucose transporter 12 (GLUT12) by electrophysiological methods. Am J Physiol Cell Physiol. 2015 Jun 15;308(12):C1008-22. doi: 10.1152/ajpcell.00343.2014. Epub 2015 Apr 8. PubMed PMID: 25855082.

2: Gu XY, Liu BL, Zang KK, Yang L, Xu H, Pan HL, Zhao ZQ, Zhang YQ. Dexmedetomidine inhibits Tetrodotoxin-resistant Nav1.8 sodium channel activity through Gi/o-dependent pathway in rat dorsal root ganglion neurons. Mol Brain. 2015 Mar 3;8:15. doi: 10.1186/s13041-015-0105-2. PubMed PMID: 25761941; PubMed Central PMCID: PMC4350947.

3: Herfindal L, Krakstad C, Myhren L, Hagland H, Kopperud R, Teigen K, Schwede F, Kleppe R, Døskeland SO. Introduction of aromatic ring-containing substituents in cyclic nucleotides is associated with inhibition of toxin uptake by the hepatocyte transporters OATP 1B1 and 1B3. PLoS One. 2014 Apr 16;9(4):e94926. doi: 10.1371/journal.pone.0094926. eCollection 2014. PubMed PMID: 24740327; PubMed Central PMCID: PMC3989234.

4: Long Y, Wang WP, Yuan H, Ma SP, Feng N, Wang L, Wang XL. Functional comparison of the reverse mode of Na+/Ca2+ exchangers NCX1.1 and NCX1.5 expressed in CHO cells. Acta Pharmacol Sin. 2013 May;34(5):691-8. doi: 10.1038/aps.2013.4. Epub 2013 Apr 8. PubMed PMID: 23564083; PubMed Central PMCID: PMC4002881.

5: Pondugula SR, Kampalli SB, Wu T, De Lisle RC, Raveendran NN, Harbidge DG, Marcus DC. cAMP-stimulated Cl- secretion is increased by glucocorticoids and inhibited by bumetanide in semicircular canal duct epithelium. BMC Physiol. 2013 Mar 27;13:6. doi: 10.1186/1472-6793-13-6. PubMed PMID: 23537040; PubMed Central PMCID: PMC3622586.

6: Jakab RL, Collaco AM, Ameen NA. Cell-specific effects of luminal acid, bicarbonate, cAMP, and carbachol on transporter trafficking in the intestine. Am J Physiol Gastrointest Liver Physiol. 2012 Oct 15;303(8):G937-50. doi: 10.1152/ajpgi.00452.2011. Epub 2012 Aug 30. PubMed PMID: 22936272; PubMed Central PMCID: PMC3469693.

7: Rambo LM, Ribeiro LR, Schramm VG, Berch AM, Stamm DN, Della-Pace ID, Silva LF, Furian AF, Oliveira MS, Fighera MR, Royes LF. Creatine increases hippocampal Na(+),K(+)-ATPase activity via NMDA-calcineurin pathway. Brain Res Bull. 2012 Sep 1;88(6):553-9. doi: 10.1016/j.brainresbull.2012.06.007. Epub 2012 Jun 26. PubMed PMID: 22742935.

8: Ghezzi C, Wright EM. Regulation of the human Na+-dependent glucose cotransporter hSGLT2. Am J Physiol Cell Physiol. 2012 Aug 1;303(3):C348-54. doi: 10.1152/ajpcell.00115.2012. Epub 2012 Jun 6. PubMed PMID: 22673616; PubMed Central PMCID: PMC3423026.

9: Lee YJ, Kim MO, Ryu JM, Han HJ. Regulation of SGLT expression and localization through Epac/PKA-dependent caveolin-1 and F-actin activation in renal proximal tubule cells. Biochim Biophys Acta. 2012 Apr;1823(4):971-82. doi: 10.1016/j.bbamcr.2011.12.011. Epub 2012 Jan 2. PubMed PMID: 22230192.

10: Tada H, Nemoto E, Foster BL, Somerman MJ, Shimauchi H. Phosphate increases bone morphogenetic protein-2 expression through cAMP-dependent protein kinase and ERK1/2 pathways in human dental pulp cells. Bone. 2011 Jun 1;48(6):1409-16. doi: 10.1016/j.bone.2011.03.675. Epub 2011 Mar 23. PubMed PMID: 21419244.

11: Beese M, Wyss K, Haubitz M, Kirsch T. Effect of cAMP derivates on assembly and maintenance of tight junctions in human umbilical vein endothelial cells. BMC Cell Biol. 2010 Sep 7;11:68. doi: 10.1186/1471-2121-11-68. PubMed PMID: 20822540; PubMed Central PMCID: PMC2941681.

12: Pelletier AM, Venkataramana S, Miller KG, Bennett BM, Nair DG, Lourenssen S, Blennerhassett MG. Neuronal nitric oxide inhibits intestinal smooth muscle growth. Am J Physiol Gastrointest Liver Physiol. 2010 Jun;298(6):G896-907. doi: 10.1152/ajpgi.00259.2009. Epub 2010 Mar 25. PubMed PMID: 20338922.

13: Russo I, Traversa M, Bonomo K, De Salve A, Mattiello L, Del Mese P, Doronzo G, Cavalot F, Trovati M, Anfossi G. In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin. Obesity (Silver Spring). 2010 Apr;18(4):788-97. doi: 10.1038/oby.2009.302. Epub 2009 Oct 15. PubMed PMID: 19834474.

14: Zhang L, Renaud LP, Kolaj M. Properties of a T-type Ca2+channel-activated slow afterhyperpolarization in thalamic paraventricular nucleus and other thalamic midline neurons. J Neurophysiol. 2009 Jun;101(6):2741-50. doi: 10.1152/jn.91183.2008. Epub 2009 Mar 25. PubMed PMID: 19321637.

15: Subramanian S, Glitz P, Kipp H, Kinne RK, Castaneda F. Protein kinase-A affects sorting and conformation of the sodium-dependent glucose co-transporter SGLT1. J Cell Biochem. 2009 Feb 15;106(3):444-52. doi: 10.1002/jcb.22025. PubMed PMID: 19115253.

16: Ramakrishnan R, Sheeladevi R, Namasivayam A. Regulation of protein kinases and coregulatory interplay of S-100beta and serotonin transporter on serotonin levels in diabetic rat brain. J Neurosci Res. 2009 Jan;87(1):246-59. doi: 10.1002/jnr.21833. PubMed PMID: 18711746.

17: Kadowaki M, Mizuno S, Demura Y, Ameshima S, Miyamori I, Ishizaki T. Effect of hypoxia and Beraprost sodium on human pulmonary arterial smooth muscle cell proliferation: the role of p27kip1. Respir Res. 2007 Nov 1;8:77. PubMed PMID: 17974037; PubMed Central PMCID: PMC2164950.

18: Matsumoto S, Yoshida S, Ikeda M, Tanimoto T, Saiki C, Takeda M, Shima Y, Ohta H. Effect of 8-bromo-cAMP on the tetrodotoxin-resistant sodium (Nav 1.8) current in small-diameter nodose ganglion neurons. Neuropharmacology. 2007 Mar;52(3):904-24. Epub 2006 Nov 29. PubMed PMID: 17140607.

19: Magenheimer BS, St John PL, Isom KS, Abrahamson DR, De Lisle RC, Wallace DP, Maser RL, Grantham JJ, Calvet JP. Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation. J Am Soc Nephrol. 2006 Dec;17(12):3424-37. Epub 2006 Nov 15. PubMed PMID: 17108316.

20: Ibe BO, Ameer A, Portugal AM, Renteria L, Raj JU. Platelet-activating factor modulates activity of cyclic nucleotides in fetal ovine pulmonary vascular smooth muscle. J Pharmacol Exp Ther. 2007 Feb;320(2):728-37. Epub 2006 Nov 3. PubMed PMID: 17085546.